Introduction: This study sought to validate a novel wavefront mapping system utilizing wholechamber basket catheters (CARTOFINDER, Biosense Webster). The system was validated in terms of (1) mapping atrial-paced beats and (2) mapping complex wavefront patterns in atrial tachycardia (AT).
INTRODUCTION
So-called "panoramic atrial mapping" using basket catheters has gained a great deal of interest due to its potential for simultaneous mapping of the whole left atrium (LA). This has formed the foundation of several mapping systems developed with the aim to identify drivers in atrial fibrillation (AF). [1] [2] [3] These technologies have had some reported success. 1, 4 A novel-mapping system (CARTOFINDER) using the CARTO platform (Biosense Webster, Inc, Diamond Bar, CA, USA) has been developed to map potential drivers in AF through identifying repetitive activation patterns that are either focal or reentrant. To achieve panoramic mapping, the system uses a 64-pole-basket catheter to acquire 30 seconds of unipolar signals through CARTO. Processing of these signals using CARTOFINDER results in wavefront propagation maps in an open format where location points and electrograms can be scrutinized. There are little data published on the use of this mapping system. Prior to being used in AF, arguably the system ought to be independently validated in terms of its ability to determine focal sources and demonstrate wavefront propagation, and perhaps also to map atrial tachycardias (ATs) with complex wavefront patterns in scarred atria. Indeed, mapping complex AT in a diseased substrate can be difficult and time consuming and may be another worthwhile application of the CARTOFINDER system if it can be shown to be effective under these difficult conditions. This study aimed to validate the CARTOFINDER mapping system by (1) localizing focal activation patterns through atrial pacing, and (2) mapping AT where the mechanism is confirmed by conventional mapping, entrainment, and ablation response.
METHODS
Patients undergoing catheter ablation for AT (de novo or post previous catheter ablation for AF) and persistent AF (< 24 months and no previous AF ablation) were prospectively included in this study. All procedures were performed with uninterrupted anticoagulation therapy and intravenous heparin administration to achieve an activated 
Electrophysiology procedure
All cases were performed with CARTO. Right and left atrial (LA) geometries were created in all patients. A high-density bipolar voltage map was created in all patients with manual points taken in sinus rhythm or AT using a PentaRay R NAV catheter (Biosense Webster, Inc). The points were respiratory gated and the interpolation threshold was set at 5 mm. Sites with a bipolar voltage of < 0.5 mV were defined as low voltage zones. 5 The maps were created with a color fill threshold of 5 mm aiming for no gray areas on the bipolar voltage map.
To collect the wavefront maps, a 50 or 60 mm 64-pole-basket catheter was used to record unipolar signals (Constellation, Boston Scientific, Natick, MA, USA and FIRMap Abbott, Menlo Park, CA, USA).
Both basket catheters have eight splines with eight electrodes on each spline. The basket catheters differ in the interelectrode spacing, whereby with the FIRMap catheter the electrodes are spaced 9 mm apart on a 60-mm catheter while 5 mm apart on a 60-mm Constellation catheter. This allows better septal coverage with the FIRMap catheter, which is a known blind spot with the Constellation catheter. 6, 7 The catheter was sized from the LA diameters obtained Through catheter manipulation, the basket catheter was positioned to achieve the best possible atrial coverage. Once in a stable position, a recording was taken with the CARTOFINDER system. A minimum of two recordings was taken per patient. The basket catheter was repositioned in between recordings to optimize coverage but also to allow for different basket catheter electrode orientations.
The CARTOFINDER system provides an evaluation of the coverage achieved as a percentage of the chamber surface area based on the LA CARTO geometry. This allows coverage to be compared between positions and so quantitatively guide catheter repositioning. In this study, electrodes that were within 10 mm of the geometry were projected onto the geometry and labeled as covering an area with a 10-mm radius. The coverage achieved including these electrodes were taken as a percentage of the geometry surface area excluding vascular and valvular structures. 7 The parameters set can be altered as per the operator's discretion. The location of the basket electrodes is determined by the CARTO system using standard advanced catheter localization (ACL) technology. It uses the same visualization technology as with any nonmagnetic sensor-based catheter (Quad, DECA, etc.). In this study, the PentaRay was used to create the anatomy and ACL matrix. However, the operator can use any NAV catheter to collect the geometry and is not limited to using the PentaRay catheter. 
CARTOFINDER system
The CARTOFINDER system records 30 seconds of unipolar signals The LAT is then determined from the annotated unipolar signals through wavelet analysis. 8 As the timing of electrograms is referenced relative to each other, no single fixed reference needs to be selected. 
Annotated atrial signals
The 30 seconds of unipolar signals with electrogram annotations were all manually reviewed for all of the maps. Out of the 64-electrode poles that recorded atrial signal, those electrodes that had inappropriate atrial signal annotation were identified. The CARTOFINDER system does allow reannotation of atrial signals followed by recreation of new maps. We evaluated the number of maps that required reannotation.
Validation with atrial pacing
To validate the system in terms of identifying focal activations during atrial pacing, atrial pacing was performed at a CL of 600 ms from four different sites: proximal and distal CS (endocardially), LA roof, and LA appendage. A recording with CARTOFINDER was taken during pacing at each site. Two operators performed the procedures, but a third and fourth blinded observer independently evaluated the maps offline to ensure they effectively demonstrated the pacing sites. The earliest activation was expected at the poles of the basket catheter that were closest to the pacing site. If the position of the basket catheter was such that more than one pole was at an equal distance from the pacing site, early activation was expected at all of these poles. All maps were reviewed to ensure the earliest activation was recorded at the poles closest to the pacing site.
Validation in AT
To validate the system's capability to identify complex activation patterns CARTOFINDER maps were created during AT and were reviewed prospectively to predict the mechanism of the AT. The time taken to record and process the maps was recorded and the time taken for the two operators to elicit a diagnosis from the CARTOFINDER maps was also noted. The diagnosis made from the CARTOFINDER maps was then compared with the actual AT mechanisms as determined by a combination of detailed conventional LAT maps created through taking manual points with the PentaRay catheter, entrainment of the tachycardia, and response to ablation. The time taken to create a LAT map from which a diagnosis of the AT could be made from was also recorded. This was compared to the total time taken to create and elicit a diagnosis from the CARTOFINDER maps. If a further AT was induced following ablation, this was also mapped with the CARTOFINDER system and evaluated as above. The third and fourth blinded observer also reviewed all the CARTOFINDER maps created in AT to ensure they agreed with the diagnosis made. Following this, they reviewed all the LAT maps to ensure these maps had established the same diagnosis.
The persistent AF patients whereby the AF organized into an AT had the AT mapped prospectively using the CARTOFINDER system.
The mechanism was again confirmed with conventional mapping, entrainment, and response to ablation. 
Statistical analysis

RESULTS
Twenty-two patients were included in this study (16 AT patients and 6 AF patients in whom AF organized into an AT during ablation). Out of the 16 AT patients, 14 patients had undergone previous ablation for AF. Baseline characteristics are shown in Table 1 . All procedures were performed successfully without any complications. The average
TA B L E 1 Baseline characteristics of the cohort
Baseline characteristics Cohort n = 22
Age years mean ± SD 64 ± 10 
Automated annotation of atrial signals
Having manually reviewed the annotated signals, the annotation of atrial signals was correct in 170 CARTOFINDER maps (98.8%), which is equivalent to a total recording of 85 minutes. In two of the maps, in one patient there was noise on two of the 64-electrodes, which was believed to have been due to damage of the electrodes during catheter insertion. The mapping system inappropriately annotated electrograms from one of these electrodes on the two maps where there was noise. This electrogram was thereby excluded from the map that was then effectively reprocessed. On all maps created, the system was able to effectively avoid annotating ventricular signals but still annotate atrial signals within the QRS complex.
Validation with atrial pacing
Validation with pacing at the four sites was performed in all 21
patients. The maps effectively demonstrated the site of focal atrial activation in all patients. There was a 100% agreement between the third and fourth blinded observers in identifying the pacing site. 
Validation in AT
Twenty-seven ATs were mapped in the 21 AT patients (1.4 ± 0.7). Table 2 demonstrates the mechanism of the 27 ATs effectively mapped with the CARTOFINDER system. The ATs were predominantly left-sided with a macroreentrant mechanism. The system mapped 18 macroreentrant ATs of which roof-dependent flutter were most common (n = 7, 38.9%). The remaining 9 ATs were focal out of which a majority was left sided (n = 7, 77.8%).
The CARTOFINDER maps created in these patients correlated to the conventional LAT maps in all cases, with the mechanisms confirmed by entrainment. Further to this, the mechanisms were confirmed by ablation that terminated the AT to sinus rhythm in all cases. Attempts were made to reinduce the AT with burst atrial pacing and extrastimuli, but the clinical AT was noninducible in all cases. The mechanism of each AT was confirmed subsequently in all 27 AT that were effec-
TA B L E 2
The mechanism of the ATs mapped by CARTOFINDER with confirmation by conventional means, entrainment, and response to ablation
ATs mapped and ablated
AT n 21
Mitral isthmus-dependent flutter Cavotricuspid isthmus-dependent flutter 3
Mitral isthmus-dependent flutter 1
Roof-dependent flutter 2 tively mapped by the third and fourth observers, who were blinded to the subsequent conventional LAT maps. In all cases, the correct mechanism was identified.
The CARTOFINDER system was thereby effectively able to map both focal/microreentrant ATs ( Figures 3A-D) and macroreentrant ATs in the LA (Figures 4A-C) and RA ( Figures 5A-C) . The AT that could not be mapped with the system due to a dilated and extensively scarred 
Follow-up data
During a follow-up of 11.6 ± 1.3 months, none of the patients had recurrence of AT. In the 6 AF patients, none had recurrence of AF as per Holter monitoring at 3, 6, 9, and 12 months.
DISCUSSION
This novel CARTOFINDER mapping system proved effective in identifying focal sources of activation during atrial pacing at different sites.
The mechanism of AT was also correctly identified in all patients, except one where adequate LA coverage was not feasible due to a dilated scarred atrium. The system was able to effectively map both focal/microreentrant ATs and macroreentrant ATs in both the LA and RA.
Mapping with the basket catheter and CARTOFINDER system
As CARTOFINDER is incorporated into the CARTO system, this facilitates use by physicians already familiar with CARTO. The operators were experienced electrophysiologists but were novices to the CARTOFINDER system, and despite the latter were still able to operate it effectively with a limited learning curve.
During electrogram analysis, the system works to identify only highquality atrial signals. Finding the right balance in excluding noise but retaining true atrial signal is essential, as together with the inevitable loss of some data through poor LA contact and limitations to coverage with the basket catheter, this will clearly have an impact on the CARTOFINDER maps created. In all cases, the system struck a balance that resulted in useful maps. Further to this, the algorithm was also able to effectively filter ventricular signals but still annotate atrial signals embedded in the QRS complex.
The CARTOFINDER maps were constructed and available to be reviewed within 2 minutes of the recording with a diagnosis established within a total time of less than 3 minutes. As a result, the operator was able to create a diagnostic map of the AT significantly quicker than was achieved with a conventional LAT map.
The CARTOFINDER system uses a 64-pole basket catheter with the aim of achieving panoramic atrial mapping. However, the quality of the maps is highly dependent on the electrogram data that can be recorded with the basket catheter. Mapping with the basket is very dependent on the degree of LA contact, the ability to record signal when in contact (i.e., the absence of widespread scar), and the LA coverage achieved with the basket catheter. Skeptics of atrial mapping with basket catheters point to the low spatial resolution of electrodes and the poor contact and coverage of the LA achieved. 9 Temporalspatial stability of the basket catheter is also a recognized limitation of these catheters. 9 In one patient, the LA contact and coverage achieved was very limited. This patient had a scarred and severely dilated LA that would account for the suboptimal recording obtained with the basket and thereby uninterpretable CARTOFINDER maps. LA coverage in the remaining patients was a little higher than other published studies at 68%. 9, 10 The ability to rapidly create multiple maps enabled catheter repositioning to achieve optimal coverage and repeat mapping, without a great impact on procedure duration. Utilizing the additional tool that calculates LA coverage enabled a quantitative evaluation when repositioning the basket catheter. We have previously reported higher LA coverage achieved in patients having mapping performed with FIRMap catheter compared to Constellation catheter. 7 Opting to use this catheter with the system could aid in the creation of more detailed maps. CARTOFINDER maps were effectively created in the RA in 6 patients, indicating that the system can be used for both left-and right-sided arrhythmias.
Mapping AT
The CARTOFINDER mapping system was able to map a range of 
Limitations
The atrial-paced beats were effectively localized using the CARTOFINDER system. The area of the earliest site of activation on the CARTOFINDER maps was dependent on the position of the basket catheter relative to the pacing site and the distance from the site of pacing to the nearest basket poles. Therefore, although CARTOFINDER maps consistently identified focal mechanisms of AT, it may not always identify the small discreet area responsible for a focal AT. This was seen to be the case when pacing the LA appendage specifically since it is removed from the body of the LA where the basket is situated. This could also apply to pulmonary vein foci if one were attempting to map in AF. It is important to consider this when mapping ATs. The current basket catheters have 64 poles. The 192-pole basket catheter that is currently undergoing CE marking will enable the creation of higher resolution CARTOFINDER maps that might potentially allow for more precise location of focal sources through improving spatial resolution. This will potentially also allow more detailed evaluation of focal ATs versus microreentrant ATs.
The CARTOFINDER system currently uses a fixed window of 0-250 ms that is used for displaying the colors of the wavefronts on the anatomical map. This window was initially set between 0 and 250 ms with the aim to map AF. However, in the next version of the CARTOFINDER system this window will be open for adjustment by the operator in accordance to the atrial arrhythmia CL. In this study, the fixed window did however not limit the interpretation of the maps.
Although we have shown here the potential of this mapping system to map complex AT in scarred atria, randomized trials are needed to determine whether this improves outcomes or procedure times compared to other mapping techniques.
CONCLUSIONS
This novel mapping system was effectively validated by mapping focal activation patterns from atrial paced beats and mapping more complex wavefront activations in AT. This system may be useful for mapping of AT in that it is rapid and does not require a stable rhythm for any length of time. The ability to map focal activations and complex wavefront patterns suggests that it could potentially be of use for mapping wavefront patterns in AF.
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